Viewing Study NCT01667432


Ignite Creation Date: 2025-12-24 @ 9:47 PM
Ignite Modification Date: 2026-01-02 @ 2:35 AM
Study NCT ID: NCT01667432
Status: COMPLETED
Last Update Posted: 2017-04-10
First Post: 2012-08-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: An Observational Study of Peginterferon Alfa-2a (PEGASYS®) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B
Sponsor: Hoffmann-La Roche
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-07-08
Start Date Type: ACTUAL
Primary Completion Date: 2014-08-12
Primary Completion Date Type: ACTUAL
Completion Date: 2014-08-12
Completion Date Type: ACTUAL
First Submit Date: 2012-08-15
First Submit QC Date: None
Study First Post Date: 2012-08-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2015-10-01
Results First Submit QC Date: None
Results First Post Date: 2015-12-07
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-03-10
Last Update Post Date: 2017-04-10
Last Update Post Date Type: ACTUAL